Exact Sciences
EXAS
#1107
Rank
NZ$36.54 B
Marketcap
NZ$191.47
Share price
0.00%
Change (1 day)
99.78%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -NZ$0.32 Billion

According to Exact Sciences's latest financial reports the company's current earnings are NZ$3.24 Billion. , an increase over its 2024 earnings that were of -NZ$1.86 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$0.34 Billion-82.05%
2024 -NZ$1.86 Billion435.05%
2023 -NZ$0.35 Billion-69.18%
2022 -NZ$1.13 Billion-25.77%
2021 -NZ$1.52 Billion1.68%
2020 -NZ$1.49 Billion271.17%
2019 -NZ$0.41 Billion58.99%
2018 -NZ$0.26 Billion20.89%
2017 -NZ$0.21 Billion-30.95%
2016 -NZ$0.31 Billion5.09%
2015 -NZ$0.29 Billion57.24%
2014 -NZ$0.19 Billion116.53%
2013 -NZ$84.5 Million
2011 -NZ$52.61 Million143.73%
2010 -NZ$21.59 Million27.85%
2009 -NZ$16.89 Million0.27%
2008 -NZ$16.84 Million-20.95%
2007 -NZ$21.3 Million-13.53%
2006 -NZ$24.64 Million-10.07%
2005 -NZ$27.4 Million-21.81%
2004 -NZ$35.04 Million-33.44%
2003 -NZ$52.64 Million-6.51%
2002 -NZ$56.3 Million17.95%
2001 -NZ$47.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
NZ$14.21 B-4,373.95%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
NZ$0.21 B-163.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$0.12 B-136.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-NZ$0.71 Billion 111.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-NZ$63.82 Million-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA